Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Pulmonary arterial hypertension: a new era in management
Author: Keogh, A.
McNeil, K.
Williams, T.
Gabbay, E.
Cleland, L.
Citation: Medical Journal of Australia, 2003; 178(11):564-567
Publisher: Australasian Med Publ Co Ltd
Issue Date: 2003
ISSN: 0025-729X
Statement of
Anne M Keogh, Keith D McNeil, Trevor Williams, Eli Gabbay and Leslie G Cleland
Abstract: Pulmonary arterial hypertension (PAH) is a heterogeneous condition with a wide range of causes. The diagnosis is often delayed or missed. PAH is covert in its early stages, when its detection and treatment should have the most impact. Access in Australia to effective PAH therapies has lagged behind that in other affluent countries. New agents for PAH, now becoming available, improve symptoms and reduce pulmonary resistance, with some demonstrating an ability to reverse remodelling of the right ventricle. Best management of PAH is comprehensive and multidisciplinary. Centres of excellence are needed in geographically strategic areas. Aggressive efforts must be made to diagnose PAH and to facilitate access to effective therapies.
Keywords: Humans
Hypertension, Pulmonary
Pulmonary Embolism
Vasodilator Agents
Referral and Consultation
Description: The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.
DOI: 10.5694/j.1326-5377.2003.tb05360.x
Published version:
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_9680.pdfPublished version497.56 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.